| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Arrest | 5 | 2018 | 321 | 1.550 |
Why?
|
| Anesthesiologists | 2 | 2018 | 46 | 1.050 |
Why?
|
| Arthroscopy | 5 | 2021 | 112 | 0.880 |
Why?
|
| Intraoperative Complications | 3 | 2015 | 194 | 0.820 |
Why?
|
| Cardiopulmonary Resuscitation | 3 | 2018 | 259 | 0.800 |
Why?
|
| Drosophila Proteins | 5 | 2022 | 538 | 0.780 |
Why?
|
| Operating Rooms | 3 | 2018 | 144 | 0.740 |
Why?
|
| Anesthesia | 4 | 2016 | 175 | 0.710 |
Why?
|
| Transforming Growth Factor beta | 3 | 2022 | 356 | 0.660 |
Why?
|
| Data Interpretation, Statistical | 2 | 2019 | 313 | 0.640 |
Why?
|
| Drosophila | 4 | 2022 | 547 | 0.620 |
Why?
|
| Hip Injuries | 1 | 2018 | 2 | 0.550 |
Why?
|
| Return to Sport | 1 | 2018 | 19 | 0.550 |
Why?
|
| Intensive Care Units | 6 | 2020 | 520 | 0.490 |
Why?
|
| Athletic Injuries | 1 | 2018 | 113 | 0.490 |
Why?
|
| Data Mining | 1 | 2016 | 45 | 0.480 |
Why?
|
| Sample Size | 1 | 2016 | 130 | 0.480 |
Why?
|
| Physician's Role | 1 | 2018 | 181 | 0.470 |
Why?
|
| Disease Management | 1 | 2018 | 377 | 0.450 |
Why?
|
| Femoracetabular Impingement | 3 | 2020 | 17 | 0.440 |
Why?
|
| Databases, Factual | 2 | 2016 | 1094 | 0.430 |
Why?
|
| Biomedical Research | 1 | 2019 | 471 | 0.420 |
Why?
|
| Clinical Alarms | 3 | 2019 | 17 | 0.410 |
Why?
|
| Molecular Imaging | 1 | 2015 | 72 | 0.410 |
Why?
|
| Limb Deformities, Congenital | 1 | 2012 | 17 | 0.370 |
Why?
|
| Clinical Trials as Topic | 2 | 2016 | 1129 | 0.360 |
Why?
|
| Informed Consent | 1 | 2015 | 284 | 0.360 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2012 | 18 | 0.360 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2015 | 238 | 0.340 |
Why?
|
| General Practice | 1 | 2011 | 9 | 0.340 |
Why?
|
| Correspondence as Topic | 1 | 2011 | 5 | 0.340 |
Why?
|
| Mammography | 1 | 2015 | 504 | 0.330 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 550 | 0.300 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 368 | 0.300 |
Why?
|
| Humans | 50 | 2021 | 98080 | 0.290 |
Why?
|
| Safety Management | 2 | 2011 | 54 | 0.270 |
Why?
|
| Mental Fatigue | 2 | 2018 | 8 | 0.270 |
Why?
|
| Referral and Consultation | 1 | 2011 | 418 | 0.260 |
Why?
|
| Postoperative Complications | 3 | 2015 | 2681 | 0.250 |
Why?
|
| Organizational Culture | 1 | 2007 | 34 | 0.250 |
Why?
|
| Hospital Units | 1 | 2007 | 29 | 0.250 |
Why?
|
| Anesthesia, General | 3 | 2011 | 130 | 0.250 |
Why?
|
| Nursing Staff, Hospital | 1 | 2007 | 46 | 0.250 |
Why?
|
| Hip Joint | 3 | 2021 | 60 | 0.220 |
Why?
|
| Drosophila melanogaster | 2 | 2022 | 652 | 0.220 |
Why?
|
| Blood Glucose | 1 | 2009 | 911 | 0.210 |
Why?
|
| Critical Illness | 6 | 2018 | 436 | 0.210 |
Why?
|
| Consciousness Monitors | 2 | 2015 | 3 | 0.200 |
Why?
|
| Pulmonary Alveoli | 2 | 2015 | 71 | 0.200 |
Why?
|
| Monitoring, Intraoperative | 2 | 2015 | 115 | 0.190 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2022 | 23 | 0.180 |
Why?
|
| Wings, Animal | 2 | 2022 | 111 | 0.180 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2022 | 51 | 0.180 |
Why?
|
| Larva | 3 | 2022 | 139 | 0.180 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2020 | 107 | 0.180 |
Why?
|
| Receptors, Cell Surface | 2 | 2022 | 291 | 0.170 |
Why?
|
| Bursitis | 1 | 2021 | 15 | 0.170 |
Why?
|
| Dogs | 2 | 2022 | 639 | 0.170 |
Why?
|
| Electroencephalography | 3 | 2011 | 789 | 0.170 |
Why?
|
| Water-Electrolyte Balance | 1 | 2001 | 72 | 0.170 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 104 | 0.170 |
Why?
|
| Lactic Acid | 1 | 2001 | 95 | 0.170 |
Why?
|
| Chlorides | 1 | 2001 | 102 | 0.170 |
Why?
|
| Emergency Medical Services | 2 | 2015 | 288 | 0.160 |
Why?
|
| Ligands | 1 | 2022 | 486 | 0.160 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 3272 | 0.160 |
Why?
|
| Awareness | 1 | 2001 | 93 | 0.160 |
Why?
|
| Blood Gas Analysis | 1 | 2020 | 35 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 1286 | 0.160 |
Why?
|
| Body Patterning | 1 | 2022 | 219 | 0.150 |
Why?
|
| Treatment Outcome | 6 | 2021 | 9711 | 0.150 |
Why?
|
| Catheters | 1 | 2020 | 109 | 0.150 |
Why?
|
| Cell Membrane | 1 | 2022 | 673 | 0.140 |
Why?
|
| Uncertainty | 1 | 2019 | 81 | 0.140 |
Why?
|
| Cartilage, Articular | 1 | 2019 | 86 | 0.140 |
Why?
|
| Respiration, Artificial | 4 | 2010 | 462 | 0.140 |
Why?
|
| Osteoarthritis, Hip | 1 | 2018 | 22 | 0.140 |
Why?
|
| Female | 20 | 2022 | 51536 | 0.140 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2019 | 336 | 0.140 |
Why?
|
| Reoperation | 2 | 2019 | 727 | 0.140 |
Why?
|
| Motion Therapy, Continuous Passive | 1 | 2018 | 1 | 0.140 |
Why?
|
| Propofol | 4 | 2001 | 95 | 0.140 |
Why?
|
| Second-Look Surgery | 1 | 2018 | 10 | 0.140 |
Why?
|
| Perioperative Period | 1 | 2018 | 31 | 0.140 |
Why?
|
| Weight-Bearing | 1 | 2018 | 72 | 0.130 |
Why?
|
| Oxygen | 2 | 2020 | 802 | 0.130 |
Why?
|
| Hemocytes | 1 | 2017 | 4 | 0.130 |
Why?
|
| Inhibin-beta Subunits | 1 | 2017 | 4 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2022 | 668 | 0.130 |
Why?
|
| Hematopoietic System | 1 | 2017 | 12 | 0.130 |
Why?
|
| Range of Motion, Articular | 1 | 2018 | 177 | 0.130 |
Why?
|
| Resuscitation | 1 | 2018 | 144 | 0.130 |
Why?
|
| Sensory Receptor Cells | 1 | 2017 | 40 | 0.130 |
Why?
|
| Middle Aged | 15 | 2021 | 29428 | 0.130 |
Why?
|
| Data Accuracy | 1 | 2016 | 33 | 0.120 |
Why?
|
| Inventions | 1 | 2016 | 16 | 0.120 |
Why?
|
| Hematopoiesis | 1 | 2017 | 186 | 0.120 |
Why?
|
| Critical Care | 2 | 2019 | 483 | 0.120 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2017 | 132 | 0.120 |
Why?
|
| Probability | 1 | 2016 | 356 | 0.120 |
Why?
|
| Research Design | 1 | 2019 | 660 | 0.110 |
Why?
|
| Machine Learning | 1 | 2019 | 408 | 0.110 |
Why?
|
| Hypotension | 1 | 2015 | 80 | 0.110 |
Why?
|
| Biomarkers | 4 | 2018 | 2020 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2016 | 268 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2016 | 284 | 0.100 |
Why?
|
| Airway Management | 1 | 2015 | 53 | 0.100 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2005 | 137 | 0.100 |
Why?
|
| Midazolam | 3 | 2000 | 48 | 0.100 |
Why?
|
| Checklist | 1 | 2014 | 78 | 0.100 |
Why?
|
| Radiation Dosage | 1 | 2015 | 231 | 0.100 |
Why?
|
| Male | 21 | 2021 | 47076 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 7389 | 0.100 |
Why?
|
| Risk Factors | 3 | 2015 | 6233 | 0.100 |
Why?
|
| Prospective Studies | 6 | 2015 | 4823 | 0.100 |
Why?
|
| Naltrexone | 3 | 2000 | 140 | 0.100 |
Why?
|
| Adult | 13 | 2018 | 29539 | 0.100 |
Why?
|
| Narcotic Antagonists | 3 | 2000 | 181 | 0.100 |
Why?
|
| Aged | 9 | 2015 | 21758 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2016 | 601 | 0.090 |
Why?
|
| Anesthesiology | 1 | 2015 | 171 | 0.090 |
Why?
|
| Hypnotics and Sedatives | 3 | 2000 | 143 | 0.090 |
Why?
|
| Perioperative Care | 1 | 2014 | 198 | 0.090 |
Why?
|
| Respiratory Insufficiency | 1 | 2015 | 211 | 0.090 |
Why?
|
| Cystatin C | 2 | 2010 | 29 | 0.090 |
Why?
|
| Esophagus | 1 | 2012 | 108 | 0.090 |
Why?
|
| Intraoperative Awareness | 1 | 2011 | 2 | 0.090 |
Why?
|
| Anal Canal | 1 | 2012 | 94 | 0.090 |
Why?
|
| Trachea | 1 | 2012 | 249 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2015 | 1527 | 0.090 |
Why?
|
| Accreditation | 1 | 2011 | 77 | 0.080 |
Why?
|
| Spine | 1 | 2012 | 147 | 0.080 |
Why?
|
| Hypocapnia | 1 | 2010 | 8 | 0.080 |
Why?
|
| Anesthetics, Inhalation | 1 | 2011 | 97 | 0.080 |
Why?
|
| Fever of Unknown Origin | 1 | 2010 | 5 | 0.080 |
Why?
|
| Arthralgia | 2 | 2021 | 44 | 0.080 |
Why?
|
| Animals | 8 | 2022 | 28894 | 0.080 |
Why?
|
| Absorptiometry, Photon | 1 | 2011 | 116 | 0.080 |
Why?
|
| Radiography | 1 | 2012 | 764 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2019 | 10973 | 0.080 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2011 | 103 | 0.080 |
Why?
|
| Electroconvulsive Therapy | 1 | 2010 | 26 | 0.080 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2000 | 161 | 0.080 |
Why?
|
| Time Factors | 6 | 2012 | 5567 | 0.080 |
Why?
|
| Age Factors | 1 | 2015 | 1962 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2014 | 1147 | 0.080 |
Why?
|
| Osteoporosis | 1 | 2011 | 135 | 0.070 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2009 | 39 | 0.070 |
Why?
|
| Cytomegalovirus Infections | 1 | 2010 | 116 | 0.070 |
Why?
|
| False Positive Reactions | 2 | 2020 | 215 | 0.070 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2009 | 87 | 0.070 |
Why?
|
| Abdominal Pain | 1 | 2010 | 148 | 0.070 |
Why?
|
| Registries | 1 | 2015 | 1122 | 0.070 |
Why?
|
| Kidney Function Tests | 1 | 2009 | 122 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2015 | 2529 | 0.070 |
Why?
|
| Monitoring, Physiologic | 2 | 2019 | 263 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2014 | 865 | 0.070 |
Why?
|
| Algorithms | 2 | 2018 | 2002 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2008 | 3620 | 0.070 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 194 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1567 | 0.070 |
Why?
|
| Infant | 1 | 2015 | 3328 | 0.070 |
Why?
|
| Activins | 1 | 2007 | 23 | 0.070 |
Why?
|
| Vision, Ocular | 1 | 2007 | 73 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2008 | 135 | 0.060 |
Why?
|
| Kidney | 1 | 2012 | 1123 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2015 | 4001 | 0.060 |
Why?
|
| Hospital Administration | 1 | 2007 | 24 | 0.060 |
Why?
|
| Seizures | 2 | 2010 | 318 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2008 | 508 | 0.060 |
Why?
|
| Axons | 1 | 2007 | 181 | 0.060 |
Why?
|
| Liver Failure, Acute | 1 | 2006 | 39 | 0.060 |
Why?
|
| United States | 3 | 2015 | 8197 | 0.060 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2005 | 9 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2010 | 372 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2008 | 314 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 412 | 0.060 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2005 | 28 | 0.060 |
Why?
|
| Brain | 2 | 2007 | 2430 | 0.050 |
Why?
|
| Heart Failure | 1 | 2015 | 1491 | 0.050 |
Why?
|
| Insulin | 1 | 2009 | 1225 | 0.050 |
Why?
|
| Gastrointestinal Transit | 2 | 2000 | 20 | 0.050 |
Why?
|
| Interleukin-8 | 2 | 2000 | 90 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2005 | 418 | 0.050 |
Why?
|
| Child | 1 | 2015 | 7681 | 0.050 |
Why?
|
| Prostatectomy | 1 | 2006 | 490 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2000 | 136 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2002 | 26 | 0.050 |
Why?
|
| Equipment Design | 2 | 2018 | 425 | 0.050 |
Why?
|
| Receptors, Steroid | 1 | 2003 | 43 | 0.050 |
Why?
|
| Chromosomes, Mammalian | 1 | 2002 | 39 | 0.050 |
Why?
|
| Morphine | 2 | 2000 | 127 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2011 | 1123 | 0.040 |
Why?
|
| Young Adult | 1 | 2015 | 7507 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2009 | 939 | 0.040 |
Why?
|
| Adolescent | 1 | 2015 | 10080 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2005 | 1445 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2003 | 332 | 0.040 |
Why?
|
| Triglycerides | 1 | 2001 | 233 | 0.040 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 200 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2001 | 155 | 0.040 |
Why?
|
| Pancreatic Elastase | 1 | 2000 | 15 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2000 | 215 | 0.040 |
Why?
|
| Drug Interactions | 2 | 2017 | 239 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2000 | 67 | 0.040 |
Why?
|
| Lipocalin-2 | 2 | 2010 | 42 | 0.040 |
Why?
|
| Genome | 1 | 2002 | 417 | 0.040 |
Why?
|
| Methadone | 1 | 2000 | 54 | 0.040 |
Why?
|
| Lipocalins | 2 | 2010 | 34 | 0.040 |
Why?
|
| Acute-Phase Proteins | 2 | 2010 | 36 | 0.040 |
Why?
|
| Wakefulness | 2 | 1997 | 128 | 0.040 |
Why?
|
| Expert Systems | 1 | 2019 | 18 | 0.040 |
Why?
|
| Knowledge Bases | 1 | 2019 | 21 | 0.040 |
Why?
|
| Constipation | 1 | 2000 | 68 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2000 | 213 | 0.040 |
Why?
|
| Cartilage Oligomeric Matrix Protein | 1 | 2018 | 2 | 0.040 |
Why?
|
| Positive-Pressure Respiration | 1 | 1999 | 55 | 0.040 |
Why?
|
| Pain | 1 | 2001 | 416 | 0.040 |
Why?
|
| Neutrophils | 1 | 2000 | 346 | 0.030 |
Why?
|
| Athletes | 1 | 2018 | 63 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 395 | 0.030 |
Why?
|
| Sleep Hygiene | 1 | 2018 | 3 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2014 | 2784 | 0.030 |
Why?
|
| Analgesics, Opioid | 2 | 2000 | 540 | 0.030 |
Why?
|
| Physical Examination | 1 | 1999 | 149 | 0.030 |
Why?
|
| Cholinergic Agonists | 1 | 2017 | 11 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2019 | 218 | 0.030 |
Why?
|
| Discrimination Learning | 1 | 2018 | 63 | 0.030 |
Why?
|
| Carbachol | 1 | 2017 | 34 | 0.030 |
Why?
|
| Peripheral Nervous System | 1 | 2017 | 21 | 0.030 |
Why?
|
| Drug Hypersensitivity | 1 | 2017 | 38 | 0.030 |
Why?
|
| Proteins | 1 | 2003 | 804 | 0.030 |
Why?
|
| Music | 1 | 2018 | 36 | 0.030 |
Why?
|
| Oxygen Consumption | 2 | 1996 | 239 | 0.030 |
Why?
|
| Cellular Microenvironment | 1 | 2017 | 33 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2019 | 1026 | 0.030 |
Why?
|
| Hepatopulmonary Syndrome | 1 | 2016 | 3 | 0.030 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2016 | 12 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 1997 | 118 | 0.030 |
Why?
|
| Auditory Perception | 1 | 2018 | 104 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2002 | 902 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2003 | 1646 | 0.030 |
Why?
|
| Cytokines | 1 | 2000 | 889 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2010 | 682 | 0.030 |
Why?
|
| Smad2 Protein | 2 | 2007 | 25 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2016 | 123 | 0.030 |
Why?
|
| Single-Blind Method | 2 | 2011 | 162 | 0.030 |
Why?
|
| Forecasting | 1 | 2016 | 295 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 1014 | 0.030 |
Why?
|
| Endotoxins | 1 | 1995 | 36 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 3 | 2000 | 82 | 0.030 |
Why?
|
| American Heart Association | 1 | 2015 | 117 | 0.030 |
Why?
|
| Hypoxia | 2 | 2016 | 699 | 0.030 |
Why?
|
| Respiratory Mechanics | 1 | 2015 | 109 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2015 | 169 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 1815 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 1995 | 286 | 0.020 |
Why?
|
| Statistics, Nonparametric | 2 | 2005 | 302 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2016 | 382 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 685 | 0.020 |
Why?
|
| Double-Blind Method | 3 | 2001 | 1782 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1995 | 572 | 0.020 |
Why?
|
| Thrombelastography | 1 | 1992 | 48 | 0.020 |
Why?
|
| Nurse Practitioners | 1 | 2011 | 36 | 0.020 |
Why?
|
| Physician Assistants | 1 | 2011 | 32 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 1992 | 140 | 0.020 |
Why?
|
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2010 | 16 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 1945 | 0.020 |
Why?
|
| Lymphocytosis | 1 | 2010 | 11 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2010 | 74 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 1110 | 0.020 |
Why?
|
| Masks | 1 | 2010 | 33 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2010 | 116 | 0.020 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2010 | 86 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 141 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 1995 | 834 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 340 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2011 | 179 | 0.020 |
Why?
|
| Semiconductors | 1 | 2009 | 11 | 0.020 |
Why?
|
| Israel | 1 | 2009 | 68 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2010 | 202 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 409 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2009 | 88 | 0.020 |
Why?
|
| Injections, Intravenous | 2 | 2001 | 212 | 0.020 |
Why?
|
| Interleukin-6 | 2 | 2000 | 282 | 0.020 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2008 | 16 | 0.020 |
Why?
|
| Mice | 1 | 2002 | 12698 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 446 | 0.020 |
Why?
|
| Disulfides | 1 | 2008 | 66 | 0.020 |
Why?
|
| Growth Cones | 1 | 2007 | 4 | 0.020 |
Why?
|
| ROC Curve | 1 | 2010 | 794 | 0.020 |
Why?
|
| alpha Karyopherins | 1 | 2007 | 10 | 0.020 |
Why?
|
| Telemedicine | 1 | 2011 | 250 | 0.020 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2007 | 25 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2007 | 32 | 0.020 |
Why?
|
| Presynaptic Terminals | 1 | 2007 | 42 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 413 | 0.020 |
Why?
|
| Physicians | 1 | 2015 | 685 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 306 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2008 | 204 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2007 | 198 | 0.020 |
Why?
|
| Supine Position | 1 | 2006 | 34 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2000 | 707 | 0.020 |
Why?
|
| Elective Surgical Procedures | 1 | 2008 | 171 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2009 | 492 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 731 | 0.020 |
Why?
|
| Mutation | 2 | 2008 | 4392 | 0.010 |
Why?
|
| Sclerosis | 1 | 2005 | 30 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2006 | 296 | 0.010 |
Why?
|
| Videotape Recording | 1 | 2005 | 49 | 0.010 |
Why?
|
| Kinetics | 1 | 2008 | 1476 | 0.010 |
Why?
|
| Alleles | 1 | 2008 | 1159 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 2005 | 188 | 0.010 |
Why?
|
| Ischemia | 1 | 2006 | 262 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 2013 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 1554 | 0.010 |
Why?
|
| Computational Biology | 1 | 2008 | 613 | 0.010 |
Why?
|
| Cell Movement | 1 | 2007 | 814 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2005 | 483 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2005 | 354 | 0.010 |
Why?
|
| Mushroom Bodies | 1 | 2003 | 3 | 0.010 |
Why?
|
| Activin Receptors, Type II | 1 | 2003 | 10 | 0.010 |
Why?
|
| Activin Receptors, Type I | 1 | 2003 | 13 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2005 | 715 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 2003 | 49 | 0.010 |
Why?
|
| Base Composition | 1 | 2002 | 36 | 0.010 |
Why?
|
| Synteny | 1 | 2002 | 31 | 0.010 |
Why?
|
| Pseudogenes | 1 | 2002 | 39 | 0.010 |
Why?
|
| Quality of Life | 1 | 2011 | 1895 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 2855 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2002 | 130 | 0.010 |
Why?
|
| RNA, Untranslated | 1 | 2002 | 70 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2002 | 195 | 0.010 |
Why?
|
| Sex Chromosomes | 1 | 2002 | 57 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2002 | 209 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 4116 | 0.010 |
Why?
|
| CpG Islands | 1 | 2002 | 177 | 0.010 |
Why?
|
| Genes | 1 | 2002 | 256 | 0.010 |
Why?
|
| Multigene Family | 1 | 2002 | 204 | 0.010 |
Why?
|
| Sex Factors | 1 | 2005 | 1138 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 303 | 0.010 |
Why?
|
| Emulsions | 1 | 2001 | 20 | 0.010 |
Why?
|
| Liver | 1 | 2006 | 1231 | 0.010 |
Why?
|
| Models, Animal | 1 | 2002 | 279 | 0.010 |
Why?
|
| Proteome | 1 | 2002 | 163 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2003 | 302 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 690 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1807 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 1888 | 0.010 |
Why?
|
| Tablets, Enteric-Coated | 1 | 2000 | 5 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2003 | 447 | 0.010 |
Why?
|
| Breath Tests | 1 | 2000 | 59 | 0.010 |
Why?
|
| Lactulose | 1 | 2000 | 22 | 0.010 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2000 | 55 | 0.010 |
Why?
|
| Auscultation | 1 | 1999 | 5 | 0.010 |
Why?
|
| Palpation | 1 | 1999 | 19 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 911 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 1604 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1999 | 244 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 839 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2000 | 674 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2002 | 663 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 4025 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 889 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 1999 | 258 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 2002 | 571 | 0.010 |
Why?
|
| Gastrointestinal Agents | 1 | 2000 | 197 | 0.010 |
Why?
|
| Genome, Human | 1 | 2002 | 832 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2002 | 2207 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2000 | 977 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 1255 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1997 | 59 | 0.010 |
Why?
|
| Actins | 1 | 2000 | 480 | 0.010 |
Why?
|
| Genomics | 1 | 2002 | 898 | 0.010 |
Why?
|
| APACHE | 1 | 1996 | 25 | 0.010 |
Why?
|
| Length of Stay | 1 | 2000 | 878 | 0.010 |
Why?
|
| Patients' Rooms | 1 | 1996 | 14 | 0.010 |
Why?
|
| Gene Expression | 1 | 2000 | 1320 | 0.010 |
Why?
|
| RNA | 1 | 2000 | 595 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1996 | 412 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1995 | 45 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1995 | 158 | 0.010 |
Why?
|
| Vasodilation | 1 | 1995 | 91 | 0.010 |
Why?
|
| Observer Variation | 1 | 1996 | 579 | 0.010 |
Why?
|
| Arginine | 1 | 1995 | 143 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1995 | 96 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 1619 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2002 | 2023 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1999 | 1782 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 3606 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1995 | 945 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1995 | 889 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1996 | 508 | 0.010 |
Why?
|
| Hematocrit | 1 | 1992 | 68 | 0.010 |
Why?
|
| Blood Coagulation Tests | 1 | 1992 | 31 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1992 | 59 | 0.010 |
Why?
|
| Intestines | 1 | 1995 | 441 | 0.010 |
Why?
|
| Heart Valve Prosthesis | 1 | 1992 | 97 | 0.010 |
Why?
|
| Drainage | 1 | 1992 | 176 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1995 | 747 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 1950 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1992 | 231 | 0.000 |
Why?
|
| Neoplasms | 1 | 2002 | 3334 | 0.000 |
Why?
|